Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.
Please see terms and conditions for restrictions on use of Citywire's Fund Manager database.

This Fund Manager Rating is based on the Citywire Absolute Return ratings methodology

Citywire Ratings are rewarded for risk adjusted outperformance and meeting specific criteria. More information on how Ratings are calculated

Henrik Rhenman

Henrik Rhenman

Showing manager performance globally. You can view performance in individual jurisdictions.

Citywire Rating: Not Rated

Performance

Alternative UCITS - Long/Short Equity
over : 31/10/2016 - 31/10/2017

Total Return

Month by Month Performance

Quarterly Performance

to 30/09/2017 Annual Q1 Q2 Q3 Q4
2017 22.2% 0.2% 3.8%
2016 -12.0% -23.1% 9.2% 8.4% -3.4%
2015 20.1% 27.3% 1.7% -18.7% 14.2%
2014 42.8% 6.3% 4.8% 10.6% 15.9%
2013 55.3% 20.8% 5.5% 15.3% 5.7%

Related News

Firm behind world-beating L/S fund hires new co-manager

New addition assigned to strategy which previously sat first in its peer group over one, three and five years.

Leading L/S manager ‘unbroken’ after short-term shock

Sector standout over three- and five-years eyes biotech amid market recoil.

Second major L/S fund reopened to investors

Healthcare-focused strategy with strong three- and five-year returns becomes latest Alt Ucits fund to end investor restrictions.

L/S equity leader hails election's ‘landslide upside’ and eyes value

Boutique founder Henrik Rhenman welcomes Proposition 61 defeat and Republican clean sweep, while assessing healthcare opportunities.

Leading L/S boutique to launch spin-off fund

Investment firm famed for outperforming healthcare approach unveils global approach designed to battle increased use of passive strategies.

Leading long/short equity manager to soft-close €500m fund

Healthcare specialist announces planned closure of top-performing strategy in sector from end of next month.

Top L/S manager challenges Clinton’s biotech price control plans

Healthcare specialist Henrik Rhenman says ‘virtually nothing’ will happen to industry following Presidential candidate’s comments.

Health and safety: how Henrik Rhenman became a long/short leader

The leading long/short equity investor outlines how he’s kept his healthcare fund fighting fit and why he is now cutting back on his best bet.

Top performing long/short equity fund nears soft-close limit

Leading Alt Ucits strategy over one, three and five-years announces €500bn ceiling is nearly reached.

Leading L/S manager warns of early year ‘recoil’ hitting investors

Top-performing Alt Ucits specialist over one, three and five years believes strong start to the year for markets will be short-lived.

...more...
Citywire Discovery Source: Citywire Discovery Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated)..Portions of the information contained on this page was derived by Citywire Financial Publishers Ltd using content supplied by Lipper, A Reuters Company.